Marilyn Huckans, Ph.D.
Assistant Professor of Psychiatry, Oregon Health & Science University
Staff Psychologist and Neuropsychologist, Portland VA Medical Center
Method of Contact
Portland VA Medical Center, P3MHN
3710 SW US Veterans Hospital Road
Portland, Oregon 97239
Phone: 503-220-8262 ext. 54689
B.S., Human Development and Family Studies, Cornell University,1996
Ph.D., Clinical Psychology, George Mason University, 2004
Neuropsychology Post-Doctoral Fellowship, Portland VA Medical Center, 2003-2007
Dr. Huckans’ translational research program integrates human, animal, and in vitro experiments to examine how neuroimmune factors contribute to the neuropsychiatric effects of medical, psychiatric, and substance use disorders. Currently, she has VA and NIH funded projects that utilize neuropsychological assessment, neuroimaging, and immunological techniques to study the cognitive and psychiatric effects of methamphetamine dependence, hepatitis C, and traumatic brain injury. Based on novel findings from her research, Dr. Huckans is also investigating immunotherapies as a potential new direction for the treatment of addictions and substance-induced cognitive and psychiatric impairments.
Dr. Huckans provides neuropsychological assessment, cognitive rehabilitation, and consultation services through the Neuropsychology Service at PVAMC. Dr. Huckans most recently developed and piloted a model group-based cognitive strategies training intervention for OIF/OEF veterans with a history of traumatic brain injury and persistent mild cognitive impairment. In an effort to move toward evidence based treatment, an adapted version of this intervention is now be evaluated through a VA-funded multi-center randomized control trial.
Dr. Huckans actively mentors and supervises graduate students and post-doctoral fellows interested in clinical and research training. As Psychology Practicum Coordinator, she coordinates clinical placements for doctoral and master’s level psychology students at PVAMC.
Selected Recent Publications
Loftis, J.M., Choi, D., Hoffman, W., & Huckans, M.S. (in press). Methamphetamine causes persistent immune dysregulation: A cross-species, translational report. Neurotoxicity Research.
Huckans, M., Seelye, A., Woodhouse, J., Parcel, T., Mull, L., Schwartz, D., Mitchell, A., Lahna, D., Johnson, A., Loftis, J., Woods, S., Mitchell, S.H., and Hoffman, W. (in press). Discounting of delayed rewards and executive dysfunction in individuals infected with hepatitis C. Journal of Clinical and Experimental Neuropsychology.
Schwartz, D.L., Mitchell, A.D., Lahna, D.L., Luber, H.S., Huckans, M.S., Mitchell, S.H., & Hoffman, W.H. (2010). Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals. Neuroimage, 50(4), 1392-401.
Loftis, J.M., Huckans, M., & Morasco, B. (2010). Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategies. Neurobiology of Disease, 37(3), pp. 519-33.
Huckans, M., Pavawalla, P., Demadura, T., Kolessar, M., Seelye, A., Twamley, E., & Storzbach, D. (2010). A pilot study examining effects of group-based cognitive strategy training treatment on self-reported cognitive problems, psychiatric symptoms, functioning, and compensatory strategy use in OIF/OEF combat veterans with persistent mild cognitive disorder and history of traumatic brain injury. Journal of Rehabilitation Research and Development, 47(1), pp. 43-60.
Huckans, M., Seelye, A., Parcel, T., Mull, L., Woodhouse, J., Bjornson, D., Loftis, J.M., Morasco, B.J., Fuller, B., Sasaki, A., Storzbach, D., & Hauser, P. (2009). The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder. Journal of the International Neuropsychological Society, 15(1), pp.69-82.